Access Statistics for Christopher James Sampson

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A Framework for Value-aligned Pricing of Combination Therapies 0 0 3 5 2 2 7 12
Barriers to Uptake of Minimal Access Surgery in the United Kingdom 0 0 1 2 2 6 12 18
Cost implications of treatment non-completion in a forensic personality disorder service 0 0 0 15 3 7 8 50
Drop Dead: Is Anchoring at ‘Dead’ a Theoretical Requirement in Health State Valuation? 0 0 1 9 4 5 12 33
Happy and healthy: a joint model of health and life satisfaction 0 0 0 87 3 8 12 295
How Should We Measure Quality of Life Impact in Rare Disease? Recent Learnings in Spinal Muscular Atrophy 0 0 2 29 6 12 21 107
How is Quality of Life Measured for Health Technology Assessments? 0 0 2 16 6 6 13 48
R&D, Competition and Diffusion of Innovation in the EU: The Case of Hepatitis C 0 0 1 1 3 4 6 9
The Case for Expanding Uptake of Next-Generation Sequencing for Lung Cancer in Europe 0 1 4 7 2 6 13 21
The Impact of New Medicines in the NHS: 70 Years of Innovation 0 0 0 1 1 4 7 12
The relationship between individual risk and cost-effectiveness in screening interventions 0 0 1 43 4 6 10 298
Total Working Papers 0 1 15 215 36 66 121 903
4 registered items for which data could not be found


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Do patients registered with CAM-trained GPs really use fewer health care resources and live longer? A response to Kooreman and Baars. Eur J Health Econ (2012). 13:469–776 0 0 0 3 4 8 13 90
Health Opportunity Costs and Expert Elicitation: A Comment on Soares et al 0 0 0 1 4 5 7 12
Is anchoring at ‘dead’ a theoretical requirement for health state valuation? 0 0 0 1 5 6 8 12
Marginal cost per QALY estimates: What are they good for? 0 0 2 10 8 12 23 55
Model Registration: A Call to Action 0 0 0 4 3 5 8 68
NICE and the EQ-5D-5L: Ten Years Trouble 1 1 1 4 2 3 7 22
Supply-Side Cost-Effectiveness Thresholds: Questions for Evidence-Based Policy 1 5 21 26 10 26 100 139
Transparency in Decision Modelling: What, Why, Who and How? 0 0 0 4 0 6 11 62
Total Journal Articles 2 6 24 53 36 71 177 460


Statistics updated 2026-02-12